REFERENCES
- Allen C., Maysinger D., Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloidal Surface B: Biointerfacial 1999; 16: 1–35
- Asano M., Yoshida M., Fukuzaki H., Kumakura M., Mashimo T., Yuasa H., Imai K., Yamanaka H. Effect of crystallinity on the in vivo degradation of poly(b-propiolactone) prepared by radiation-induced solid polymerization in organic solvent system at low temperature. Eur. Poly. J. 1990; 26: 29–33, [CROSSREF]
- Brode G. L., Koleske J. V. Lactone polymerization and polymer properties. J. Macromol. Sci.-Chem. 1972; A6: 1109–1144
- Cerrai P., Tricoli M., Andruzzi F. Polyether-polyester block copolymers by non-catalyzed polymerization of ε -caprolactone with poly(ethylene glycol). Polymer 1989; 30: 338–343, [CROSSREF]
- Hseih G. L., Wang I. W. Ring-Opening Polymerization. ACS, Washington, D.C. 1985
- Klibanov A. L., Maruyama K., Torchilin V. P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268: 235–237, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kim S. Y., Ha J. C., Lee Y. M. Poly(ethyleen oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(ε -caprolactone) amphiphilic block copolymeric nanospheres II. Thermo-responsive drug release behaviors. J. Control. Rel. 2000; 65: 345–358, [CROSSREF], [CSA]
- Kwon G. S. Diblock copolymer nanoparticles for drug delivery. Critical Rev. Therap. Drug Carrier Sys. 1998; 15: 481–512, [CSA]
- Pitt C. G., Gratzl M. M., Kimmel G. L., Surles J., Schindler A. Aliphatic polyesters II. The degradation of poly(DL-lactide), poly(ε -caprolactone), and their copolymers in vivo. Biomaterials 1981; 2: 215–220, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shin I. G., Kim S. Y., Lee Y. M., Cho C. S., Sung Y. K. Methoxy poly(ethylene glycol)/ε -caprolactone amphiphilic block copolymeric micelle containing indomethacin: I. Preparation and characterization. J. Control. Rel. 1998; 51: 1–11, [CROSSREF], [CSA]
- Stolnik S., Illum L., Davis S. S. Long-circulating microparticulate drug carriers. Adv. Drug Del. Rev. 1995; 16: 195–214, [CROSSREF], [CSA]
- Saez A., Guzman M., Molpeceres J., Aberturas M. R. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic)nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm. 2000; 50: 379–387, [PUBMED], [CROSSREF], [CSA]
- Torchilin V. P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Rel. 2001; 73: 137–172, [CROSSREF], [CSA]